Interleukin-3 (IL-3) is a growth factor that supports the proliferation and differentiation of early hematopoietic stem cells as well as committed progenitors of the myeloid lineages. The long term goal of this proposal is to determine the mechanisms by which IL-3 regulates growth and differentiation by using a series of IL-3-dependent myeloid cell lines. The cells require IL-3 for maintenance of viability, progression through the cell cycle and for the expression of genes including c-myc, c-fos, c- pim-1 and ornithine decarboxylase. The studies proposed in this application will identify genes that are involved in the early events in signal transduction. In the first specific aim, we will pursue our studies which demonstrated that IL-3 binds to cause the rapid tyrosine phosphorylation of a cell surface 140 kDa protein. Using large scale purifications with anti-phosphotyrosine monoclonal antibody resins we propose to purify, sequence and obtain cDNAs clones for pp140. The cDNA clones would be used to study IL-3 bindings, the ability to mediate IL-3 specific signal transduction and the possible role of pp140 in transformation. In the second specific aim we will purify, sequence and obtain cDNA clones for other substrates of IL-3 induced tyrosine phosphorylation. The products of these cDNAs will be characterized for their role in IL-3 signal transduction and transformation of hematopoietic cells. In the last specific aim, we propose to clone unique early hematopoietic lineage specific protein tyrosine kinases by using oligonucleotide probes to conserved domains. Experiments are proposed to determine whether they encode the receptors for known hematopoietic growth factors or contribute to the mechanisms by which IL-3 regulates growth or gene expression. Together these approaches will identify new genes that are involved in the growth regulation of hematopoietic cells and better our understanding of the growth and differentiation of myeloid cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042932-05
Application #
2142644
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1990-08-01
Project End
1995-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Gingras, Sebastien; Earls, Laurie R; Howell, Sherie et al. (2015) SCYL2 Protects CA3 Pyramidal Neurons from Excitotoxicity during Functional Maturation of the Mouse Hippocampus. J Neurosci 35:10510-22
Pelletier, Stephane; Gingras, Sebastien; Howell, Sherie et al. (2012) An early onset progressive motor neuron disorder in Scyl1-deficient mice is associated with mislocalization of TDP-43. J Neurosci 32:16560-73
Funakoshi-Tago, Megumi; Pelletier, Stephane; Moritake, Hiroshi et al. (2008) Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol 28:1792-801
Gingras, Sebastien; Pelletier, Stephane; Boyd, Kelli et al. (2007) Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP). PLoS One 2:e808
Funakoshi-Tago, Megumi; Pelletier, Stephane; Matsuda, Tadashi et al. (2006) Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J 25:4763-72
Pelletier, Stephane; Gingras, Sebastien; Funakoshi-Tago, Megumi et al. (2006) Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol 26:8527-38
Mead, Paul E; Parganas, Evan; Ohtsuka, Shiro et al. (2005) Evi-1 expression in Xenopus. Gene Expr Patterns 5:601-8
Carpino, Nick; Turner, Steve; Mekala, Divya et al. (2004) Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20:37-46
Schuendeln, Michael M; Piekorz, Roland P; Wichmann, Christian et al. (2004) The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol 24:6403-9
Carpino, Nick; Thierfelder, William E; Chang, Ming-shi et al. (2004) Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol 24:2584-92

Showing the most recent 10 out of 72 publications